Employees Retirement System of Texas trimmed its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 17.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,000 shares of the medical instruments supplier’s stock after selling 5,000 shares during the period. Employees Retirement System of Texas owned about 0.12% of ICU Medical worth $3,968,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. grew its holdings in ICU Medical by 87,088.7% during the 1st quarter. BlackRock Inc. now owns 1,769,930 shares of the medical instruments supplier’s stock worth $270,268,000 after acquiring an additional 1,767,900 shares during the period. Janus Capital Management LLC grew its holdings in ICU Medical by 178.8% during the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after acquiring an additional 923,395 shares during the period. Fiera Capital Corp acquired a new stake in ICU Medical during the 2nd quarter worth about $36,962,000. Vanguard Group Inc. grew its holdings in ICU Medical by 16.3% during the 2nd quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock worth $224,989,000 after acquiring an additional 183,133 shares during the period. Finally, Redmile Group LLC acquired a new stake in ICU Medical during the 1st quarter worth about $24,515,000. Institutional investors and hedge funds own 78.13% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.watchlistnews.com/employees-retirement-system-of-texas-sells-5000-shares-of-icu-medical-inc-icui/1617682.html.

In related news, Director Robert S. Swinney sold 4,477 shares of the business’s stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $175.00, for a total transaction of $783,475.00. Following the transaction, the director now owns 23,293 shares in the company, valued at $4,076,275. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Scott E. Lamb sold 2,998 shares of the business’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $170.13, for a total transaction of $510,049.74. Following the transaction, the chief financial officer now owns 9,050 shares in the company, valued at approximately $1,539,676.50. The disclosure for this sale can be found here. Insiders have sold 143,998 shares of company stock worth $24,630,363 in the last quarter. 15.90% of the stock is owned by corporate insiders.

A number of analysts have weighed in on the company. BidaskClub downgraded ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 target price for the company in a research note on Thursday, July 20th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $193.00.

Shares of ICU Medical, Inc. (NASDAQ:ICUI) opened at 191.85 on Friday. ICU Medical, Inc. has a 52 week low of $127.00 and a 52 week high of $192.65. The firm has a market capitalization of $3.80 billion, a P/E ratio of 76.83 and a beta of 0.35. The stock has a 50 day moving average price of $179.24 and a 200 day moving average price of $167.37.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The company had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. During the same quarter in the prior year, the firm earned $1.15 EPS. ICU Medical’s quarterly revenue was up 242.8% compared to the same quarter last year. Analysts forecast that ICU Medical, Inc. will post $4.11 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.